Biomarkers for Endocrine gland cancer

1. TG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. TP53
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. MUC16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. BRCA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. RET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. CALCB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. NTRK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. AKT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. ERBB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. BRCA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. ER
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. CEACAM5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. NR4A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. EGFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. BCL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. PR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. CDKN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. BRAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. MAPK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. ESR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. Ki-67
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. MYC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. HRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. KRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. PIK3CA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. MEN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. AFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. ATM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. FBXW7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. GNAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. AR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. APC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. MUC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. MTOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. JUN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. ITK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. SDHB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. CTLA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. SMAD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. KIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. SRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. FAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. VHL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. FGFR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. RB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. CDKN1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. MS4A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. TIMP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. PRKAR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. MLH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. ROS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. KDR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. IL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. STAT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. HIF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. LDH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. Beta-hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. ELN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. POLE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. CCDC6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. FANCA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. POU5F1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. PAX8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. NRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. WFDC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. MAX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. SERPINE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. SPEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. CgA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. MSH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. BRD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. NKX2-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. ENO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. PTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. ABL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. uPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. CXCR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. CDC73
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. MDM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. WT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. TSHR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. CDK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. NF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. CTNNB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. DDIT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. FH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. NCOA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. SDHD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. STK11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. NCKIPSD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. PTPRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. FUS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. MYCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. SDHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. ABCG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. TP63
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. ERBB3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. CALR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. MET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. PRF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. TERT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. ARID1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. SDHC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. CHEK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. SMAD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. MAP2K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. RAF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. SOX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. FOXP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. CDX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. PSA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. HSP90AA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. CD79A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. HMGA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. CCND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. ABL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. AKT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. GOPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. PDGFRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. RHOA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. SMAD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. CUX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. ARID1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. EZH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. MSH6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. MDM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. PALB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. NOTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. CDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. FOXL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. RAC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. PDCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. CDKN2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. LMNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. KCNJ5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. BCR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. RARA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. BLM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. CD274
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. DICER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. NFE2L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. FLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. JAK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. PPFIBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. NBN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. EP300
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. FHIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. ATR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. CREBBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. PMS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. CDK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. HLA-A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. ERCC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. NF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. STIL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. CASP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. SMARCA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. TSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. TMEM127
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. ERBB4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. CDH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. FOXO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. HMGA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. TRIM27
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. CCNE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. FGFR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. PPARG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. KMT2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. MAP2K4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. REL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. BRIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. MYD88
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. TRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. FGFR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. SDHAF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. MYB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. PIM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. CLIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. FANCD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. NT5C2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. SMARCB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. SSX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. ATRX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. EWSR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. FGFR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. FOXO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. DAXX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. FUBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. YWHAE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. AXIN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. DNMT3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. ETV6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. PDGFRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. PTPN11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. STAT5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. KLF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. TSC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. XPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. PDGFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. HER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. GPC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. IL6ST
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. BIRC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. CACNA1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. IGH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. TOP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. ATP1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. EPAS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. ERCC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. NDRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. ZNF198
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. ATP2B3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. MAP3K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. CBL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. BUB1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. TGFBR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. AXIN2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. CYLD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. RUNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. TAL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. CCND2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. ETV4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. FLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. IDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. KEAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. KLK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. PTEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. CARS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. ERCC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. NTRK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. PCSK7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. ARNT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. ERCC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. HNF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. NRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. SOCS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. CIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. ERG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. GATA3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. HOXA9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. JAK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. MAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. PML
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. ACVR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. B2M
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. DROSHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. FANCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. IDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. RNF43
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. XPO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. MECOM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. MUTYH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. NOTCH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. NPM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. PMS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. TFRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. ZNF331
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. BCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. FOXP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. TBL1XR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. BCL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. ETV5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. FANCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. FEV
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. KLF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. MSN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. PICALM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. SND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. TNFAIP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. TPR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. U2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. XPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. HOXD13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. PPM1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. SPECC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. CDK12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. FES
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. MAP2K2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. NUTM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. WAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. CD74
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. CIITA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. COL1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. ELF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. EXT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. GNAQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. PTPN13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. RAD51B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. AKAP9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. CANT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. CTCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. HEY1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. KMT2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. LIFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. TFG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. TNFRSF17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. USP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. Neurokinin
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301. BAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
302. BMPR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
303. DDX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
304. EBF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
305. FANCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
306. FOXA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
307. IL7R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
308. JAK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
309. KMT2D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
310. LCK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
311. MYOD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
312. RPL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
313. SS18
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
314. TPM3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
315. WRN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
316. EML4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
317. FLI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
318. HOXA11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
319. MALAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
320. NCOR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
321. PAX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
322. PIK3R1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
323. PTK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
324. SYK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
325. TCF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
326. TCF7L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
327. WHSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
328. CYP2D6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
329. BCL9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
330. ERC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
331. FLCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
332. IKZF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
333. KDM6A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
334. LRP1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
335. NSD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
336. PAX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
337. PDCD1LG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
338. PLCG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
339. PRCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
340. RALGDS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
341. RECQL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
342. SSX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
343. TBX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
344. TFE3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
345. TOP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
346. TRRAP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
347. ACVR2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
348. ALDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
349. CCND3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
350. CHIC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
351. CRTC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
352. DNM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
353. GOLGA5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
354. HERPUD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
355. IGL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
356. KDM5C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
357. MALT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
358. MITF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
359. MNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
360. NCOR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
361. PBRM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
362. PRDM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
363. SEPT9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
364. STAT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
365. TET1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
366. TRIM33
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
367. WIF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
368. BTG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
369. BTK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
370. DDB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
371. EIF4A2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
372. GNA11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
373. LCP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
374. LEF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
375. LMO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
376. MLLT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
377. MYCL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
378. NFATC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
379. NUP214
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
380. OLIG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
381. PBX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
382. PER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
383. POT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
384. SEPT5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
385. SETBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
386. SFPQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
387. SRSF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
388. SUZ12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
389. TCL1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
390. CEP17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
391. ARID2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
392. ATF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
393. BCL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
394. BRD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
395. CEBPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
396. CNBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
397. HOXA13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
398. MPL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
399. PCM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
400. PLAG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
401. STRN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
402. SUFU
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
403. TFEB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
404. TMPRSS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
405. TRIM24
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
406. UBR5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
407. WWTR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
408. ZBTB16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
409. ABI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
410. CAMTA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
411. CREB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
412. CREB3L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
413. DDX3X
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
414. DDX6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
415. DEK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
416. DNAJB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
417. GRIN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
418. HSP90AB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
419. KIF5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
420. LASP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
421. LPP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
422. MAML2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
423. MED12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
424. MKL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
425. MLLT11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
426. MSI2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
427. NIN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
428. NUMA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
429. PAX7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
430. POU2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
431. PRRX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
432. RANBP2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
433. RSPO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
434. SBDS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
435. SF3B1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
436. SH2B3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
437. SH3GL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
438. SMARCE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
439. TET2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
440. TNFRSF14
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
441. AFF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
442. AMER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
443. APOBEC3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
444. BCL11A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
445. BCOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
446. CARD11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
447. CASC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
448. CHD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
449. CREB3L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
450. DDR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
451. ETNK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
452. ETV1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
453. EZR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
454. FAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
455. FAT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
456. FCGR2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
457. FGFR1OP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
458. GMPS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
459. HLF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
460. HNRNPA2B1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
461. HOOK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
462. IRF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
463. JAZF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
464. KTN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
465. MAFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
466. MLLT10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
467. NCOA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
468. NCOA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
469. NONO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
470. OMD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
471. PHOX2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
472. PRDM16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
473. RBM10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
474. RSPO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
475. RUNX1T1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
476. SMO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
477. SSX4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
478. TRD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
479. TTL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
480. PAM50
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
481. CD52
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
482. ARHGAP26
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
483. CLP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
484. CLTC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
485. COL2A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
486. DDX10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
487. DUX4L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
488. ELK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
489. ELL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
490. EXT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
491. FAM46C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
492. FANCE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
493. FBXO11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
494. FOXO4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
495. GATA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
496. GATA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
497. H3F3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
498. H3F3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
499. HIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
500. HOXC13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
501. HOXD11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
502. IGK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
503. KDM5A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
504. KDSR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
505. LRIG3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
506. LSM14A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
507. LZTR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
508. MLLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
509. MLLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
510. MN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
511. MYH9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
512. MYO5A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
513. NAB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
514. NFKB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
515. PPP6C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
516. PREX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
517. PSIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
518. QKI
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
519. RAP1GDS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
520. RHOH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
521. SDC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
522. SLC45A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
523. SMARCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
524. SPOP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
525. SRSF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
526. STAG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
527. TAL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
528. TCF12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
529. THRAP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
530. TLX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
531. TPM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
532. TRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
533. USP6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
534. WHSC1L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
535. ZNF278
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
536. ZNF521
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
537. ZRSR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
538. Cytokeratin fragment 21-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
539. MK167
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
540. SET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
541. ACKR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
542. ACSL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
543. ACSL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
544. AFF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
545. AFF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
546. ARHGEF12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
547. ASPSCR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
548. ASXL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
549. ATIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
550. BCL11B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
551. BCL5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
552. BCL7A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
553. BCL9L
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
554. BCORL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
555. C12orf9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
556. C15orf65
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
557. C2orf44
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
558. CBFA2T3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
559. CBFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
560. CBLB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
561. CBLC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
562. CCNB1IP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
563. CD79B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
564. CEP89
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
565. CHCHD7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
566. CLTCL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
567. CNOT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
568. CNTRL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
569. COX6C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
570. CRLF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
571. CRTC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
572. CSF3R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
573. DCTN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
574. ECT2L
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
575. EIF3E
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
576. EPS15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
577. FAM131B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
578. FCRL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
579. FIP1L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
580. FNBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
581. FSTL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
582. GAS7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
583. GPHN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
584. HIST1H3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
585. HIST1H4I
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
586. HMGN2P46
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
587. HOXC11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
588. IKBKB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
589. IL21R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
590. KAT6A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
591. KAT6B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
592. KIAA1549
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
593. KIAA1598
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
594. LHFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
595. LMO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
596. LYL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
597. MAP3K13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
598. MDS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
599. MLF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
600. MLLT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
601. MTCP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
602. MYH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
603. NACA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
604. NFIB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
605. NFKBIE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
606. NUP98
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
607. NUTM2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
608. NUTM2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
609. P2RY8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
610. PAFAH1B2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
611. PDE4DIP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
612. PHF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
613. PPP2R1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
614. PRKACA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
615. PTPRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
616. PTPRK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
617. PTPRT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
618. PWWP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
619. RABEP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
620. RAD21
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
621. RANBP17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
622. RBM15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
623. RMI2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
624. RNF213
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
625. RNF217-AS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
626. RPL22
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
627. RPL5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
628. RPN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
629. RUNDC2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
630. SALL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
631. SEPT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
632. SETD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
633. SFRP4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
634. SLC34A2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
635. SRGAP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
636. SS18L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
637. TAF15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
638. TCEA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
639. TCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
640. TFPT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
641. TLX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
642. TRAF7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
643. TRIP11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
644. VTI1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
645. ZCCHC8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
646. ZFHX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
647. ZNF384
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
648. IHC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
649. MAP-Tau mRNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
650. Nuclear matrix protein 22
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
651. CAD-ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]